The 10th Joint MSKCC/HSS/IOR Course in Musculoskeletal Tumor Pathology and Clinical Oncology

This well-received annual course is designed to give a current review of musculoskeletal tumor pathology and principles of management to orthopaedic surgeons, radiation oncologists, medical oncologists, radiologists and pathologists. This course covers the most common and clinically relevant benign and malignant musculoskeletal tumors from diagnosis to integrated treatment and outcome.

This course is in collaboration with Hospital for Special Surgery and Instituto Ortopedico Rizzoli, Bologna, Italy.

Course Topics

• Benign Non Surgical & Surgical Lesions - Aneurysmal Bone Cyst, Bone Cyst, Chondromyxoid Fibroma, Chondroblastoma, Chondromas, Desmoplastic fibroma, Eosinophilic granuloma, Fibrous dysplasia, Giant cell tumor, Histiocytic fibroma, Myositis ossificans, Osteoblastoma, Osteochondromas, Osteoid osteoma
• Malignant Tumors - Adamantinoma, Chondrosarcomas, Chordoma, Ewing’s sarcoma, Lymphoma,  Myeloma, Osteosarcomas, Secondary Malignancies, Spindle and Pleomorphic Sarcomas, Vascular Tumors, Bone Metastases
• Soft Tissue Tumors - Lipoma and Other Benign Soft Tissue Tumors, Liposarcoma, Fibrosarcoma, Malignant Fibrous Histiocytoma, Synovial Sarcomal, Rare Entities
• Various - Biological Prognostic and Therapeutic Markers, Bone Allografts in Skeletal Reconstruction, Chemotherapy Issues and Future Trends, Integrated Treatment of Soft Tissue Sarcomas, Reconstruction in Children, Staging and Biopsy and Margins, Surgical Principles of Benign Lesions, Surgical Treatment of Spine Tumors 
• Special Sessions - Basic Research, Molecular Biology in the Diagnosis of Bone and Soft Tissue Tumors, Imaging of Bone and Soft Tissue Tumors, Limb Salvage Surgery

Atlas of Musculoskeletal Tumors and Tumorlike Lesions

MSK is excited to offer a significantly discounted rate of $80 for all course attendees to purchase the Atlas of Musculoskeletal Tumors and Tumorlike Lesions textbook during registration. This textbook will be a valuable resource to refer to during the course. Please note that course attendees are highly encouraged to have a copy of this textbook; however, it is not a requirement.

Sponsors

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grant and financial support for this live activity:

• ONKOS Surgical
• Zimmer Biomet

1. Participants will learn the essentials for a rationale approach to diagnosis and management of the most common bone and soft tissue tumors and tumor-like conditions
2. Current multimodal management of bone and soft tissue malignancies, including surgery, radiotherapy, chemotherapy and novel systemic options, will be extensively discussed along with future perspectives.
3. Clinical, pathologic and molecular features of the various entities will be reviewed and discussed, with emphasis on differential diagnosis. For bone lesions in particular, an articulated multidisciplinary pattern recognition approach based on clinico-radiographic and pathologic correlation will be highlighted.
4. The format will include interactive sessions for questions and case presentation, in order to practice multidisciplinary approach to diagnosis and management. The main topics of each day will be reviewed the next day during an early morning interactive session of numerous board-like multiple-choice questions.

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

• Special Resident Group Rate - MSK is offering a special group discounted rate for residents. Please contact [email protected] for more information or to register for the group rate. 

• 30% Discounted Rate for MSK Alumni and MSK Alliance Members - MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for more information or to register.

• MSK Staff Registration -MSK staff interested in registering for this course should join the waitlist. We will notify you before the course is space is available. 
  

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 24.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.